● Not Yet Recruiting

Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects With Healed Erosive Esophagitis

Condition: Maintenance of Healed Erosive Gastroesophageal Reflux Disease (ERD) · Sponsor: Onconic Therapeutics Inc.

PhasePhase 3

Planned participants384

Who can joinAll sexes, 19 Years to 75 Years

Healthy volunteersNo

About this study

This study aims to evaluate the Efficacy and Safety of JP-1366 as Maintenance Therapy in Subjects with Healed Erosive Esophagitis

This description comes directly from the study's public registry record.

Talk to the study team

OnconicTherapeutics · 82-2-3454-0780 · onconictherapeutics@gmail.com

Always discuss trial participation with your own doctor first.

Locations (0)

Locations not yet listed on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07732075